RAPP EDWARD J — SEC insider filings
SEC reporting owner CIK 1171780. 58 insider filings on record with FilingPulse; latest filed 2026-10-13.
Transaction summary — filings shown
Covers the 50 most recent of 58 filings on record, filed 2021-11-15 to 2026-10-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 400,000 shares, $633,820 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 52.
- Largest priced transaction: purchase of 100,000 shares @ $4.27 ($426,820) in Xos, Inc., filed 2021-11-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Xos, Inc. (XOS) | Director | 25 | 2 legs · 400,000 sh · $633,820 | — | 27 |
| AbbVie Inc. (ABBV) | Director | 25 | — | — | 25 |
Insider filings — RAPP EDWARD J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-13 | 4 | Xos, Inc. (XOS) | Grant/award (A): 1,814 @ $0 | EDGAR |
| 2026-10-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 129 (derivative) @ $261.59 | EDGAR |
| 2026-07-14 | 4 | Xos, Inc. (XOS) | Grant/award (A): 2,670 @ $0 · Grant/award (A): 60,584 @ $0 | EDGAR |
| 2026-07-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 134 (derivative) @ $251.64 | EDGAR |
| 2026-05-12 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,118 @ $0 | EDGAR |
| 2026-04-14 | 4 | Xos, Inc. (XOS) | Grant/award (A): 5,182 @ $0 | EDGAR |
| 2026-04-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 155 (derivative) @ $217.49 | EDGAR |
| 2026-01-13 | 4 | Xos, Inc. (XOS) | Grant/award (A): 2,401 @ $0 | EDGAR |
| 2026-01-05 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 147 (derivative) @ $228.49 | EDGAR |
| 2025-10-14 | 4 | Xos, Inc. (XOS) | Grant/award (A): 1,883 @ $0 | EDGAR |
| 2025-10-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 145 (derivative) @ $231.54 | EDGAR |
| 2025-07-14 | 4 | Xos, Inc. (XOS) | Grant/award (A): 62,377 @ $0 · Grant/award (A): 1,601 @ $0 | EDGAR |
| 2025-07-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 177 (derivative) @ $185.62 | EDGAR |
| 2025-05-13 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,203 @ $0 | EDGAR |
| 2025-04-30 | 4 | Xos, Inc. (XOS) | Grant/award (A): 1,407 @ $0 | EDGAR |
| 2025-04-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 155 (derivative) @ $209.52 | EDGAR |
| 2025-02-26 | 4/A | Xos, Inc. (XOS) | Grant/award (A): 1,475 @ $0 | EDGAR |
| 2025-01-14 | 4 | Xos, Inc. (XOS) | Grant/award (A): 1,065 @ $0 | EDGAR |
| 2025-01-03 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 182 (derivative) @ $177.70 | EDGAR |
| 2024-12-17 | 4 | Xos, Inc. (XOS) | Grant/award (A): 1,065 @ $0 | EDGAR |
| 2024-10-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 164 (derivative) @ $197.48 | EDGAR |
| 2024-07-12 | 4 | Xos, Inc. (XOS) | Grant/award (A): 28,694 @ $0 · Grant/award (A): 717 @ $0 | EDGAR |
| 2024-07-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 225 (derivative) @ $171.52 | EDGAR |
| 2024-05-07 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,322 @ $0 | EDGAR |
| 2024-04-12 | 4 | Xos, Inc. (XOS) | Grant/award (A): 445 @ $0 | EDGAR |
| 2024-04-02 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 212 (derivative) @ $182.10 | EDGAR |
| 2024-01-17 | 4 | Xos, Inc. (XOS) | Grant/award (A): 650 @ $0 | EDGAR |
| 2024-01-03 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 250 (derivative) @ $154.97 | EDGAR |
| 2023-10-12 | 4 | Xos, Inc. (XOS) | Grant/award (A): 15,151 @ $0 | EDGAR |
| 2023-10-03 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 259 (derivative) @ $149.06 | EDGAR |
| 2023-07-13 | 4 | Xos, Inc. (XOS) | Grant/award (A): 15,151 @ $0 | EDGAR |
| 2023-07-05 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 287 (derivative) @ $134.73 | EDGAR |
| 2023-06-14 | 4 | Xos, Inc. (XOS) | Grant/award (A): 444,444 @ $0 | EDGAR |
| 2023-05-09 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,450 @ $0 | EDGAR |
| 2023-04-04 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 243 (derivative) @ $159.37 | EDGAR |
| 2023-04-04 | 4 | Xos, Inc. (XOS) | Grant/award (A): 7,936 @ $0 | EDGAR |
| 2023-01-12 | 4 | Xos, Inc. (XOS) | Grant/award (A): 7,936 @ $0 | EDGAR |
| 2023-01-03 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 239 (derivative) @ $161.61 | EDGAR |
| 2022-12-02 | 4 | Xos, Inc. (XOS) | Purchase (P): 300,000 @ $0.69 | EDGAR |
| 2022-10-04 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 288 (derivative) @ $134.21 | EDGAR |
| 2022-10-04 | 4 | Xos, Inc. (XOS) | Grant/award (A): 3,378 @ $0 | EDGAR |
| 2022-09-14 | 4 | Xos, Inc. (XOS) | Grant/award (A): 115,606 @ $0 | EDGAR |
| 2022-08-05 | 4 | Xos, Inc. (XOS) | Grant/award (A): 3,816 @ $0 | EDGAR |
| 2022-07-05 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 237 (derivative) @ $153.16 | EDGAR |
| 2022-05-09 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 1,421 @ $0 | EDGAR |
| 2022-04-04 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 217 (derivative) @ $162.11 | EDGAR |
| 2022-01-04 | 4 | Xos, Inc. (XOS) | Grant/award (A): 1,474 @ $0 | EDGAR |
| 2022-01-04 | 4 | AbbVie Inc. (ABBV) | Grant/award (A): 260 (derivative) @ $135.40 | EDGAR |
| 2021-11-22 | 4 | Xos, Inc. (XOS) | Purchase (P): 100,000 @ $4.27 | EDGAR |
| 2021-11-15 | 4 | Xos, Inc. (XOS) | Grant/award (A): 57,229 (derivative) · Grant/award (A): 31,794 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1171780 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs